PBYI vs. TPH

In the year-to-date period, PBYI achieves a -1.64% return, which is significantly higher than TPH's -16.35% return. Over the past 10 years, PBYI has underperformed TPH with an annualized return of -34.20%, while TPH has yielded a comparatively higher 7.70% annualized return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Puma Biotechnology, Inc. (PBYI) and Tri Pointe Homes, Inc. (TPH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current PBYI Sharpe Ratio is -0.57, which is comparable to the TPH Sharpe Ratio of -0.52. The chart below compares the historical Sharpe Ratios of PBYI and TPH, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Neither PBYI nor TPH has paid dividends to shareholders.

The maximum PBYI drawdown since its inception was -99.40%, which is greater than TPH's maximum drawdown of -70.06%. Use the drawdown chart below to compare losses from any high point for PBYI and TPH. For additional features, visit the drawdowns tool.

Puma Biotechnology, Inc. (PBYI) and Tri Pointe Homes, Inc. (TPH) have volatilities of 12.91% and 12.97%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.

This section allows you to compare key financial metrics between Puma Biotechnology, Inc. and Tri Pointe Homes, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.